title: GWAS-based association between RWDD3 and TECTA variants and paclitaxel induced neuropathy could not be confirmed in Scandinavian ovarian cancer patients.
authors.forename: Troels K
authors.initials: TK
authors.lastname: Bergmann
authors.forename: Werner
authors.initials: W
authors.lastname: Vach
authors.forename: Søren
authors.initials: S
authors.lastname: Feddersen
authors.forename: Lise
authors.initials: L
authors.lastname: Eckhoff
authors.forename: Henrik
authors.initials: H
authors.lastname: Gréen
authors.forename: Jørn
authors.initials: J
authors.lastname: Herrstedt
authors.forename: Kim
authors.initials: K
authors.lastname: Brosen
mesh_terms: D000972:Antineoplastic Agents, Phytogenic / Q000009:adverse effects* / Q000627:therapeutic use; D002277:Carcinoma / Q000188:drug therapy / Q000453:epidemiology / Q000235:genetics*; D016326:Extracellular Matrix Proteins / Q000235:genetics*; D005260:Female; D058851:GPI-Linked Proteins / Q000235:genetics; D020022:Genetic Predisposition to Disease; D055106:Genome-Wide Association Study; D006801:Humans; D009422:Nervous System Diseases / Q000139:chemically induced* / Q000235:genetics*; D010051:Ovarian Neoplasms / Q000188:drug therapy / Q000453:epidemiology / Q000235:genetics*; D017239:Paclitaxel / Q000009:adverse effects* / Q000627:therapeutic use; D020641:Polymorphism, Single Nucleotide / Q000502:physiology; D015203:Reproducibility of Results; D012189:Retrospective Studies; D012537:Scandinavian and Nordic Countries / Q000453:epidemiology; D054928:Validation Studies as Topic
chemical_list: D000972:Antineoplastic Agents, Phytogenic; D016326:Extracellular Matrix Proteins; D058851:GPI-Linked Proteins; C491350:TECTA protein, human; D017239:Paclitaxel